Literature DB >> 2390261

Topical delivery of ciclosporin: evaluation of various formulations using in vitro diffusion studies in hairless mouse skin.

K Egbaria1, C Ramachandran, N Weiner.   

Abstract

The kinetics and extent of uptake of ciclosporin in various strata of hairless mouse skin upon topical application of several ciclosporin formulations were determined by in vitro diffusion cell experiments. The ciclosporin formulations tested included a hydroalcoholic solution, an oil-in-water emulsion and two liposomal systems. The accumulation of drug in stratum corneum is in the order: 'skin lipid' liposomes greater than 'phospholipid' liposomes greater than emulsion greater than hydroalcoholic solution. The total combined amount of drug in the deeper skin strata and the receiver compartment followed the order: hydroalcoholic solution much greater than 'phospholipid' liposomes greater than 'skin lipid' liposomes greater than emulsion. The results suggest that topically applied liposomes, particularly those prepared from lipid mixtures having compositions similar to the stratum corneum, may provide sustained, enhanced levels of ciclosporin in the stratum corneum (the reservoir) while minimizing high levels in strata associated with blood and lymph supplies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390261     DOI: 10.1159/000210837

Source DB:  PubMed          Journal:  Skin Pharmacol        ISSN: 1011-0283


  3 in total

1.  Acute and subchronic (28-day) oral toxicity study in rats fed with novel surfactants.

Authors:  Ranjit Madhukar Bidhe; Sangita Ghosh
Journal:  AAPS J       Date:  2004       Impact factor: 4.009

Review 2.  Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications.

Authors:  Yi-Qun Yu; Xue Yang; Xiao-Fang Wu; Yi-Bin Fan
Journal:  Front Bioeng Biotechnol       Date:  2021-03-29

Review 3.  Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages.

Authors:  Parisa Ghasemiyeh; Soliman Mohammadi-Samani
Journal:  Drug Des Devel Ther       Date:  2020-08-12       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.